Plasma brain natriuretic peptide levels in normotensive Type 2 diabetic patients without cardiac disease and macroalbuminuria

被引:24
作者
Asakawa, H [1 ]
Fukui, T [1 ]
Tokunaga, K [1 ]
Kawakami, F [1 ]
机构
[1] Itami City Hosp, Dept Endocrinol & Metab, Itami, Hyogo 6648540, Japan
关键词
brain natriuretic peptide (BNP); retinopathy; microalbuminuria; macroangiopathy;
D O I
10.1016/S1056-8727(01)00173-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To clarify the relationship of the plasma brain natriuretic peptide (BNP) levels to diabetic complications, we studied plasma BNP levels in 100 normotensive diabetic patients without clinical cardiac disease and macroalbuminuria. The values of plasma BNP levels were not significantly different between patients with microalbuminuria and those with nonnoalbuminuria (12.2 +/- 2.0 vs. 12.3 +/- 1.3 pg/ml, means +/- S.E.M.), and neither were the BNP levels of patients with and without retinopathy significantly different (15.7 +/- 3.4 vs. 11.4 +/- 1.0 pg/ ml). BNP levels of the subjects with cerebral vascular disease (CVD) were not statistically different from those of subjects without CVD (17.5 +/- 5.5 vs. 11.7 +/- 1.0 pg/ml), although mean BNP value of subjects with CVD was higher than that of subjects without it. With regard to peripheral vascular disease (PVD), BNP levels of the subjects with PVD were not statistically different from those of subjects without PVD (13.5 +/- 2.3 vs. 12.1 +/- 1.2 pg/ml). We also studied radial arterial oxygen tension of 45 patients and compared these levels between those with and without diabetic complications. However, we could not find statistical differences between them. In conclusion, our study suggests that BNP and arterial oxygen tension levels will not be affected by retinopathy, microalbuminuria, CVD, and PVD in normotensive diabetic patients without clinical cardiac disease and macroalbuminuria. Therefore, when normotensive diabetic patients without macro-albuminuria show increased plasma level of BNP, we should examine their cardiac function in detail, considering subclinical cardiac disease. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:209 / 213
页数:5
相关论文
共 26 条
  • [11] Linsenmeier RA, 1998, INVEST OPHTH VIS SCI, V39, P1647
  • [12] Hypoxic induction of vascular endothelial growth factor is markedly decreased in diabetic individuals who do not develop retinopathy
    Marsh, S
    Nakhoul, FM
    Skorecki, K
    Rubin, A
    Miller, BP
    Leibu, R
    Levy, NS
    Levy, AP
    [J]. DIABETES CARE, 2000, 23 (09) : 1375 - 1380
  • [13] PROSPECTIVE-STUDY OF MICROALBUMINURIA AS PREDICTOR OF MORTALITY IN NIDDM
    MATTOCK, MB
    MORRISH, NJ
    VIBERTI, G
    KEEN, H
    FITZGERALD, AP
    JACKSON, G
    [J]. DIABETES, 1992, 41 (06) : 736 - 741
  • [14] NAKAO K, 1992, J HYPERTENS, V10, P907
  • [15] A PROSPECTIVE POPULATION-BASED STUDY OF MICROALBUMINURIA AS A PREDICTOR OF MORTALITY IN NIDDM
    NEIL, A
    HAWKINS, M
    POTOK, M
    THOROGOOD, M
    COHEN, D
    MANN, J
    [J]. DIABETES CARE, 1993, 16 (07) : 996 - 1003
  • [16] Epidural spinal cord electrical stimulation in diabetic critical lower limb ischemia
    Petrakis, IE
    Sciacca, V
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 1999, 13 (5-6) : 293 - 299
  • [17] Pirart J., 1978, DIABETES CARE, V1, P168, DOI DOI 10.2337/DIACARE.1.3.168
  • [18] THE INFLUENCE OF AGE, SEX, SMOKING, AND DIABETES ON LOWER-LIMB TRANSCUTANEOUS OXYGEN-TENSION IN PATIENTS WITH ARTERIAL OCCLUSIVE DISEASE
    ROOKE, TW
    OSMUNDSON, PJ
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (01) : 129 - 132
  • [19] SHINODA T, 1990, CLIN NEPHROL, V34, P202
  • [20] vanRiemsdijk IC, 1997, KIDNEY INT, V52, P567